​

LSD is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include definium reports positive phase 3 results for single-dose dt120 in generalized anxiety disorder, definium's lsd-based drug succeeds in third phase 3 anxiety trial, definium's lsd-based pill reduces depression symptoms in late-stage trial, among other significant events and policy changes.

Source: Geo Health Space